Overview

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The main goal of this research study is to determine whether treating patients with renal cell cancer with hydroxychloroquine before surgery can make the cancer easier to kill. Another goal is to see how the study drug affects the body's immune cells which fight cancer cells.
Phase:
Phase 1
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Institutes of Health (NIH)
Treatments:
Hydroxychloroquine